Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Polarimetric Sensitivity to Torsion in Spun Highly Birefringent Fibers.

Kowal D, Statkiewicz-Barabach G, Bernas M, Napiorkowski M, Makara M, Czyzewska L, Mergo P, Urbanczyk W.

Sensors (Basel). 2019 Apr 5;19(7). pii: E1639. doi: 10.3390/s19071639.

2.

Experimental Analysis of Bragg Reflection Peak Splitting in Gratings Fabricated Using a Multiple Order Phase Mask.

Statkiewicz-Barabach G, Tarnowski K, Kowal D, Mergo P.

Sensors (Basel). 2019 Jan 21;19(2). pii: E433. doi: 10.3390/s19020433.

3.

Measurement of birefringence and ellipticity of polarization eigenmodes in spun highly birefringent fibers using spectral interferometry and lateral point-force method.

Kowal D, Statkiewicz-Barabach G, Napiorkowski M, Makara M, Poturaj K, Mergo P, Urbanczyk W.

Opt Express. 2018 Dec 24;26(26):34185-34199. doi: 10.1364/OE.26.034185.

PMID:
30650846
4.

Twin-Core Fiber-Based Mach Zehnder Interferometer for Simultaneous Measurement of Strain and Temperature.

Kowal D, Urbanczyk W, Mergo P.

Sensors (Basel). 2018 Mar 20;18(3). pii: E915. doi: 10.3390/s18030915.

5.

Elective transfers of preterm neonates to regional centres on non-invasive respiratory support is cost effective and increases tertiary care bed capacity.

Zein H, Yusuf K, Paul R, Kowal D, Thomas S.

Acta Paediatr. 2018 Jan;107(1):52-56. doi: 10.1111/apa.14059. Epub 2017 Sep 25.

PMID:
28871602
6.

Quality Improvement Study on New Endotracheal Tube Securing Device (Neobar) in Neonates.

K Loganathan P, Nair V, Vine M, Kostecky L, Kowal D, Soraisham A.

Indian J Pediatr. 2017 Jan;84(1):20-24. doi: 10.1007/s12098-016-2231-y. Epub 2016 Sep 19.

PMID:
27641975
7.

Mechanical heterogeneities in the subendothelial matrix develop with age and decrease with exercise.

Kohn JC, Chen A, Cheng S, Kowal DR, King MR, Reinhart-King CA.

J Biomech. 2016 Jun 14;49(9):1447-1453. doi: 10.1016/j.jbiomech.2016.03.016. Epub 2016 Mar 16.

8.

Reply to "Imaging of Tuberous Sclerosis".

Manoukian SB, Kowal DJ.

AJR Am J Roentgenol. 2016 Feb;206(2):W43. doi: 10.2214/AJR.15.15534. No abstract available.

PMID:
26797379
9.

Inscription of long period gratings using an ultraviolet laser beam in the diffusion-doped microstructured polymer optical fiber.

Kowal D, Statkiewicz-Barabach G, Mergo P, Urbanczyk W.

Appl Opt. 2015 Jul 10;54(20):6327-33. doi: 10.1364/AO.54.006327.

PMID:
26193411
10.

'Get Trained'.

Kowal DL.

Am J Nurs. 2015 Jul;115(7):13. doi: 10.1097/01.NAJ.0000467257.55136.7b. No abstract available.

PMID:
26110936
11.

Comprehensive imaging manifestations of tuberous sclerosis.

Manoukian SB, Kowal DJ.

AJR Am J Roentgenol. 2015 May;204(5):933-43. doi: 10.2214/AJR.13.12235. Review.

PMID:
25905927
12.

Probing the biophysical properties of primary breast tumor-derived fibroblasts.

Alcoser TA, Bordeleau F, Carey SP, Lampi MC, Kowal DR, Somasegar S, Varma S, Shin SJ, Reinhart-King CA.

Cell Mol Bioeng. 2015 Mar;8(1):76-85.

13.

Microstructured polymer optical fiber for long period gratings fabrication using an ultraviolet laser beam.

Kowal D, Statkiewicz-Barabach G, Mergo P, Urbanczyk W.

Opt Lett. 2014 Apr 15;39(8):2242-5. doi: 10.1364/OL.39.002242.

PMID:
24978963
14.

Fabrication of multiple Bragg gratings in microstructured polymer fibers using a phase mask with several diffraction orders.

Statkiewicz-Barabach G, Tarnowski K, Kowal D, Mergo P, Urbanczyk W.

Opt Express. 2013 Apr 8;21(7):8521-34. doi: 10.1364/OE.21.008521.

PMID:
23571941
15.

The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise?

Sukoff Rizzo SJ, Leonard SK, Gilbert A, Dollings P, Smith DL, Zhang MY, Di L, Platt BJ, Neal S, Dwyer JM, Bender CN, Zhang J, Lock T, Kowal D, Kramer A, Randall A, Huselton C, Vishwanathan K, Tse SY, Butera J, Ring RH, Rosenzweig-Lipson S, Hughes ZA, Dunlop J.

J Pharmacol Exp Ther. 2011 Jul;338(1):345-52. doi: 10.1124/jpet.110.177378. Epub 2011 Apr 20.

PMID:
21508084
16.

Birth Control.

Hatcher RA, Kowal D.

In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 174.

17.

Annular pancreas: Radiologic features of a case with recurrent acute pancreatitis.

Saghir A, Motarjem P, Kowal DJ, Midkiff B, Gupta P.

Radiol Case Rep. 2015 Nov 6;6(3):459. doi: 10.2484/rcr.v6i3.459. eCollection 2011.

18.

Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT(6) antagonists.

Liu KG, Robichaud AJ, Greenfield AA, Lo JR, Grosanu C, Mattes JF, Cai Y, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Comery TA.

Bioorg Med Chem. 2011 Jan 1;19(1):650-62. doi: 10.1016/j.bmc.2010.10.033. Epub 2010 Oct 20.

PMID:
21093272
19.

5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists.

Liu KG, Robichaud AJ, Bernotas RC, Yan Y, Lo JR, Zhang MY, Hughes ZA, Huselton C, Zhang GM, Zhang JY, Kowal DM, Smith DL, Schechter LE, Comery TA.

J Med Chem. 2010 Nov 11;53(21):7639-46. doi: 10.1021/jm1007825.

PMID:
20932009
20.

Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system.

Chanda PK, Gao Y, Mark L, Btesh J, Strassle BW, Lu P, Piesla MJ, Zhang MY, Bingham B, Uveges A, Kowal D, Garbe D, Kouranova EV, Ring RH, Bates B, Pangalos MN, Kennedy JD, Whiteside GT, Samad TA.

Mol Pharmacol. 2010 Dec;78(6):996-1003. doi: 10.1124/mol.110.068304. Epub 2010 Sep 20.

PMID:
20855465
21.

Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).

Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U.

J Med Chem. 2010 Jun 10;53(11):4379-89. doi: 10.1021/jm901692q.

PMID:
20465311
22.

Potent dihydroquinolinone dopamine D2 partial agonist/serotonin reuptake inhibitors for the treatment of schizophrenia.

Yan Y, Zhou P, Rotella DP, Feenstra R, Kruse CG, Reinders JH, van der Neut M, Lai M, Zhang J, Kowal DM, Carrick T, Marquis KL, Pausch MH, Robichaud AJ.

Bioorg Med Chem Lett. 2010 May 1;20(9):2983-6. doi: 10.1016/j.bmcl.2010.02.105. Epub 2010 Mar 3.

PMID:
20347298
23.

Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonism.

Dwyer JM, Platt BJ, Rizzo SJ, Pulicicchio CM, Wantuch C, Zhang MY, Cummons T, Leventhal L, Bender CN, Zhang J, Kowal D, Lu S, Rajarao SJ, Smith DL, Shilling AD, Wang J, Butera J, Resnick L, Rosenzweig-Lipson S, Schechter LE, Beyer CE.

Int J Neuropsychopharmacol. 2010 Oct;13(9):1193-205. doi: 10.1017/S1461145709991088. Epub 2010 Jan 5.

PMID:
20047711
24.

Development of an improved IP(1) assay for the characterization of 5-HT(2C) receptor ligands.

Zhang JY, Kowal DM, Nawoschik SP, Dunlop J, Pausch MH, Peri R.

Assay Drug Dev Technol. 2010 Feb;8(1):106-13. doi: 10.1089/adt.2009.0205.

PMID:
19922239
25.

Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophrenia.

Rotella DP, McFarlane GR, Greenfield A, Grosanu C, Robichaud AJ, Denny RA, Feenstra RW, Núñez-García S, Reinders JH, Neut Mv, McCreary A, Kruse CG, Sullivan K, Pruthi F, Lai M, Zhang J, Kowal DM, Carrick T, Grauer SM, Navarra RL, Graf R, Brennan J, Marquis KL, Pausch MH.

Bioorg Med Chem Lett. 2009 Oct 1;19(19):5552-5. doi: 10.1016/j.bmcl.2009.08.050. Epub 2009 Aug 15.

PMID:
19720528
26.

Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligands.

Liu KG, Lo JR, Comery TA, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Robichaud AJ.

Bioorg Med Chem Lett. 2009 Jun 15;19(12):3214-6. doi: 10.1016/j.bmcl.2009.04.108. Epub 2009 May 3.

PMID:
19433358
27.

1-Sulfonylindazoles as potent and selective 5-HT6 ligands.

Liu KG, Lo JR, Comery TA, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Robichaud AJ.

Bioorg Med Chem Lett. 2009 May 1;19(9):2413-5. doi: 10.1016/j.bmcl.2009.03.071. Epub 2009 Mar 21.

PMID:
19345582
28.

Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.

Roncarati R, Scali C, Comery TA, Grauer SM, Aschmi S, Bothmann H, Jow B, Kowal D, Gianfriddo M, Kelley C, Zanelli U, Ghiron C, Haydar S, Dunlop J, Terstappen GC.

J Pharmacol Exp Ther. 2009 May;329(2):459-68. doi: 10.1124/jpet.108.150094. Epub 2009 Feb 17.

PMID:
19223665
29.

Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists.

Heinrich JN, Butera JA, Carrick T, Kramer A, Kowal D, Lock T, Marquis KL, Pausch MH, Popiolek M, Sun SC, Tseng E, Uveges AJ, Mayer SC.

Eur J Pharmacol. 2009 Mar 1;605(1-3):53-6. doi: 10.1016/j.ejphar.2008.12.044. Epub 2009 Jan 11.

PMID:
19168056
30.

Identification of a series of benzoxazoles as potent 5-HT6 ligands.

Liu KG, Lo JR, Comery TA, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Robichaud AJ.

Bioorg Med Chem Lett. 2009 Feb 15;19(4):1115-7. doi: 10.1016/j.bmcl.2008.12.107. Epub 2009 Jan 3.

PMID:
19152787
31.

Prodrugs of perzinfotel with improved oral bioavailability.

Baudy RB, Butera JA, Abou-Gharbia MA, Chen H, Harrison B, Jain U, Magolda R, Sze JY, Brandt MR, Cummons TA, Kowal D, Pangalos MN, Zupan B, Hoffmann M, May M, Mugford C, Kennedy J, Childers WE Jr.

J Med Chem. 2009 Feb 12;52(3):771-8. doi: 10.1021/jm8011799.

PMID:
19146418
32.

Old and new pharmacology: positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B/C) receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']di pyrrole-1(2H)-carboxamide).

Dunlop J, Lock T, Jow B, Sitzia F, Grauer S, Jow F, Kramer A, Bowlby MR, Randall A, Kowal D, Gilbert A, Comery TA, Larocque J, Soloveva V, Brown J, Roncarati R.

J Pharmacol Exp Ther. 2009 Mar;328(3):766-76. doi: 10.1124/jpet.108.146514. Epub 2008 Dec 2.

PMID:
19050173
33.

Scintillation proximity assay in lead discovery.

Khawaja X, Dunlop J, Kowal D.

Expert Opin Drug Discov. 2008 Nov;3(11):1267-80. doi: 10.1517/17460441.3.11.1267.

PMID:
23496165
34.

Development of a scintillation proximity assay binding method for the human 5-hydroxytryptamine 6 receptor using intact cells.

Carrick T, Kowal D, Nawoschik S, Zhang G, Chan K, Dunlop J.

Anal Biochem. 2008 Oct 1;381(1):27-32. doi: 10.1016/j.ab.2008.06.013. Epub 2008 Jun 13.

PMID:
18601889
35.

A regiospecific synthesis of a series of 1-sulfonyl azepinoindoles as potent 5-HT6 ligands.

Liu KG, Lo JR, Comery TA, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Robichaud AJ.

Bioorg Med Chem Lett. 2008 Jul 15;18(14):3929-31. doi: 10.1016/j.bmcl.2008.06.030. Epub 2008 Jun 13.

PMID:
18583130
36.

Building a statewide knowledge network for clinicians in intensive care units: knowledge brokering and the NSW Intensive Care Coordination and Monitoring Unit (ICCMU).

Rolls K, Kowal D, Elliott D, Burrell AR.

Aust Crit Care. 2008 Feb;21(1):29-37. doi: 10.1016/j.aucc.2007.10.003. Epub 2008 Jan 15.

PMID:
18226542
37.

In vitro screening strategies for nicotinic receptor ligands.

Dunlop J, Roncarati R, Jow B, Bothmann H, Lock T, Kowal D, Bowlby M, Terstappen GC.

Biochem Pharmacol. 2007 Oct 15;74(8):1172-81. Epub 2007 Jul 10.

PMID:
17706607
38.

Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373).

Jow F, Tseng E, Maddox T, Shen R, Kowal D, Dunlop J, Mekonnen B, Wang K.

Assay Drug Dev Technol. 2006 Aug;4(4):443-50.

PMID:
16945016
39.

Distinct functional profiles of aripiprazole and olanzapine at RNA edited human 5-HT2C receptor isoforms.

Zhang JY, Kowal DM, Nawoschik SP, Lou Z, Dunlop J.

Biochem Pharmacol. 2006 Feb 14;71(4):521-9. Epub 2005 Dec 5.

PMID:
16336943
40.

Synthesis and biological activities of aryl-ether-, biaryl-, and fluorene-aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT-2.

Greenfield A, Grosanu C, Dunlop J, McIlvain B, Carrick T, Jow B, Lu Q, Kowal D, Williams J, Butera J.

Bioorg Med Chem Lett. 2005 Nov 15;15(22):4985-8.

PMID:
16165356
41.

Characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT2.

Dunlop J, McIlvain HB, Carrick TA, Jow B, Lu Q, Kowal D, Lin S, Greenfield A, Grosanu C, Fan K, Petroski R, Williams J, Foster A, Butera J.

Mol Pharmacol. 2005 Oct;68(4):974-82. Epub 2005 Jul 13.

PMID:
16014807
42.

Validation of an atomic absorption rubidium ion efflux assay for KCNQ/M-channels using the ion Channel Reader 8000.

Wang K, McIlvain B, Tseng E, Kowal D, Jow F, Shen R, Zhang H, Shan QJ, He L, Chen D, Lu Q, Dunlop J.

Assay Drug Dev Technol. 2004 Oct;2(5):525-34.

PMID:
15671650
43.

Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor.

Junaid MA, Kowal D, Barua M, Pullarkat PS, Sklower Brooks S, Pullarkat RK.

Am J Med Genet A. 2004 Nov 15;131(1):11-7.

44.

The effect of oxidative stress on amyloid precursor protein processing in cells engaged in beta-amyloidosis is related to apolipoprotein E genotype.

Mazur-Kolecka B, Kowal D, Sukontasup T, Dickson D, Frackowiak J.

Acta Neuropathol. 2004 Oct;108(4):287-94. Epub 2004 Jun 19.

PMID:
15221339
46.

Evaluation of FLIPR Calcium 3 Assay Kit--a new no-wash fluorescence calcium indicator reagent.

Zhang Y, Kowal D, Kramer A, Dunlop J.

J Biomol Screen. 2003 Oct;8(5):571-7.

PMID:
14567785
47.

WAY-855 (3-amino-tricyclo[2.2.1.02.6]heptane-1,3-dicarboxylic acid): a novel, EAAT2-preferring, nonsubstrate inhibitor of high-affinity glutamate uptake.

Dunlop J, Eliasof S, Stack G, McIlvain HB, Greenfield A, Kowal D, Petroski R, Carrick T.

Br J Pharmacol. 2003 Nov;140(5):839-46. Epub 2003 Sep 29.

49.

The effect of oxidative stress on accumulation of apolipoprotein E3 and E4 in a cell culture model of beta-amyloid angiopathy (CAA).

Mazur-Kolecka B, Kowal D, Sukontasup T, Dickson D, Frackowiak J.

Brain Res. 2003 Sep 5;983(1-2):48-57.

PMID:
12914965
50.

Characterization of the 5-HT6 receptor coupled to Ca2+ signaling using an enabling chimeric G-protein.

Zhang JY, Nawoschik S, Kowal D, Smith D, Spangler T, Ochalski R, Schechter L, Dunlop J.

Eur J Pharmacol. 2003 Jul 4;472(1-2):33-8.

PMID:
12860470

Supplemental Content

Support Center